Posts tagged CDK inhibitor
FDA Approves Verzenio (Abemaciclib) for Early Breast Cancer
FDA Approves Verzenio (Abemaciclib) for Early Breast Cancer

Verzenio was already approved to treat advanced breast cancer. Now, the FDA just gave Verzenio an additional approval to treat early breast cancer. Read on to learn more about how Verzenio works and what side effects to expect.

Read More
WellnessRoss PhanVerzenio, Abemaciclib, HR+/HER2- breast cancer, hormone positive breast cancer, HER2 negative breast cancer, early breast cancer, CDK inhibitor, advanced breast cancer, side effects, expensive medications, limited distribution drug, LDD, specialty pharmacy, lower risk of cancer coming back, targeted therapy, Ross PhanComment